Hjem › Juvenil myelomonocytisk leukemi › Washington
Kliniske studier for Juvenil myelomonocytisk leukemi i Washington
3 studier for Juvenil myelomonocytisk leukemi søker deltakere på steder i Washington.
Byer i Washington
Offisiell studietekst (engelsk)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Seattle Children's Hospital, Seattle
RekruttererFase 1/2
1 Month – 21 Years · Alle kjønn · Oppdatert 4. sep. 2026 · NCT05849662The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Seattle Children's Hospital, Seattle
- Providence Sacred Heart Medical Center and Children's Hospital, Spokane
- Mary Bridge Children's Hospital and Health Center, Tacoma
- og 1 flere
RekruttererFase 1/2
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RekruttererFase 1
Opp til 80 år · Alle kjønn · Oppdatert 18. mai 2026 · NCT03326921Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.